Ondansetron

Available EU dossier in development (available soon)

Offer available for: licensing

Pharmaceutical form and dosage: 4-8 mg Tablets

Type:

- Generics
- Pharmaceuticals / Therapeutics

Therapeutic target:

Full Description:
Ondansetron dossier:
Soon available for licensing depending on territory
-Available: II/2002

Availability and Market information:

Status: Registration

Market information

Other Market Info:

Patent Information:
Name: Zofran
Patent expiration date: 2005
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.